Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

244
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
244
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

279
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
279
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

305
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
305
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

692
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
692
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

388
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
388
Inflammation01:38

Inflammation

61.2K
Overview
61.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative platelet reactivity over time in patients undergoing vascular surgery: An observational pilot study.

PloS one·2024
Same author

A critical appreciation of pathway analysis in atherosclerotic disease. Cellular phenotypic plasticity as an illustrative example.

Vascular pharmacology·2024
Same author

Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitus.

Cardiovascular diabetology·2022
Same author

The hypoxia-sensor carbonic anhydrase IX affects macrophage metabolism, but is not a suitable biomarker for human cardiovascular disease.

Scientific reports·2021
Same author

Improved Upper Limit on the Neutrino Mass from a Direct Kinematic Method by KATRIN.

Physical review letters·2019
Same author

Effect of vagus nerve stimulation on tissue damage and function loss in a mouse myocardial ischemia-reperfusion model.

Autonomic neuroscience : basic & clinical·2019
Same journal

Atherectomy plus stenting: what do we gain?

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of directional coronary atherectomy for the treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of rotablator for treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

Directional coronary atherectomy: optimal atherectomy trials and new combined strategies with coronary stents.

Seminars in interventional cardiology : SIIC·2001
Same journal

Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.

Seminars in interventional cardiology : SIIC·2001
Same journal

Morphological analysis of atherosclerotic plaque retrieved by coronary atherectomy.

Seminars in interventional cardiology : SIIC·2001
See all related articles

Related Experiment Videos

Arterial remodelling by atherosclerosis

G Pasterkamp1, B Hillen, C Borst

  • 1Department of Cardiology, Utrecht University Hospital, The Netherlands. g.pasterkamp hli.azu.nl

Seminars in Interventional Cardiology : SIIC
|July 3, 1998
PubMed
Summary
This summary is machine-generated.

Arterial remodeling, not just plaque, significantly impacts atherosclerotic narrowing. Understanding the mechanisms behind arterial remodeling is crucial for developing new treatments to manage this cardiovascular disease.

Related Experiment Videos

Area of Science:

  • Cardiovascular Science
  • Pathology
  • Medical Imaging

Background:

  • Plaque formation was historically viewed as the sole cause of atherosclerotic luminal narrowing.
  • Recent studies highlight arterial remodeling as a critical factor in de novo atherosclerosis.
  • Arterial remodeling encompasses a spectrum from enlargement to shrinkage, affecting lumen size.

Purpose of the Study:

  • To investigate the role of arterial remodeling in atherosclerotic luminal narrowing.
  • To explore the mechanisms underlying the diverse arterial remodeling responses in atherosclerosis.
  • To identify targets for therapeutic strategies promoting favorable arterial remodeling.

Main Methods:

  • Utilized post-mortem studies to examine arterial morphology.
  • Employed intravascular ultrasound to assess arterial dimensions in vivo.
  • Analyzed changes in total arterial circumference relative to reference cross-sections.

Main Results:

  • Confirmed that arterial remodeling is a significant determinant of luminal narrowing in de novo atherosclerosis.
  • Observed a range of arterial remodeling responses, including enlargement and shrinkage.
  • Demonstrated that arterial shrinkage contributes to lumen narrowing.

Conclusions:

  • Arterial remodeling is a key factor in atherosclerotic luminal narrowing, alongside plaque formation.
  • The mechanisms driving the spectrum of arterial remodeling require further investigation.
  • Identifying these mechanisms is essential for developing therapies to improve cardiovascular outcomes.